The supraciliary space,
made safe and predictable

MINIject®S is iSTAR Medical’s revolutionary, supraciliary MIGS device.

The uveoscleral drainage pathway is known to lower IOP significantly1; The negative pressure gradient from the anterior chamber to the supraciliary space evacuates aqueous humor, unhindered by an episcleral venous pressure floor. MINIject®S now allows ophthalmic surgeons to harness this potential in a safe and predictable way. MINIject®S combines a smart way to access the supraciliary space with a uniquely designed, soft and flexible implant which has proven its long-term safety and sustained efficacy in lowering IOP2

Smart. Safe. Sustained.

Smart access

The advanced nitinol delivery sheath enables a smooth and predictable implantation.
It provides a direct view of the green ring on the MINIject implant, which signifies the correct implantation depth in the supraciliary space.

Safe implant

The MINIject® implant is made of soft, flexible and bio-integrating STAR® material.
Its unique, interconnecting network of hollow spheres enables a natural outflow of fluid along the implant into surrounding tissues.2

Sustained efficacy

Harnessing the power of the supraciliary space, MINIject®S is delivering a significant and sustained reduction of intraocular pressure (IOP). Clinical data reveal a 36% reduction in mean IOP at the three-year mark, with 42% of patients remaining medication-free.1

1 Preliminary results at 3 years. Pooled data for STAR-I, II, III trials on file.

2 Grierson I, Minckler D, Rippy MK, et al “A novel suprachoroidal microinvasive glaucoma implant: in vivo biocompatibility and biointegration.” BMC biomed eng 2, 10 (2020).

Designed for a more predictable procedure

To improve handling and storage, the secondary packaging has been reduced in size by


Hexagon Hexagon Hexagon Hexagon
scroll to up
Sign up to receive company news alerts